Rigel Pharmaceuticals RIGL Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's asset turnover?
- Rigel Pharmaceuticals (RIGL) reported asset turnover of 0.9× in Q1 2026.
- How has Rigel Pharmaceuticals's asset turnover changed year-over-year?
- Rigel Pharmaceuticals's asset turnover decreased by 34.4% year-over-year, from 1.3× to 0.9×.
- What is the long-term trend for Rigel Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's asset turnover has grown at a 0.6% compound annual growth rate (CAGR), from 0.8× to 0.9×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.